Oncternal Therapeutics, Inc.
ONCT · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,479 | -$44,170 | -$31,333 | -$17,225 |
| Dep. & Amort. | $0 | -$75 | $169 | $150 |
| Deferred Tax | $0 | $0 | -$169 | -$150 |
| Stock-Based Comp. | $7,500 | $7,431 | $5,875 | $1,556 |
| Change in WC | $1,274 | -$69 | -$1,300 | -$1,675 |
| Other Non-Cash | -$1,459 | $179 | $169 | -$151 |
| Operating Cash Flow | -$32,164 | -$36,704 | -$26,589 | -$17,495 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$64,349 | -$26,498 | $0 | $0 |
| Inv. Sales/Matur. | $65,000 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$26,498 | $0 | $0 |
| Investing Cash Flow | $651 | -$26,498 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $301 |
| Stock Issued | $1,224 | $9,582 | $617 | $113,876 |
| Stock Repurch. | -$156 | -$3 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $617 | $4 |
| Financing Cash Flow | $1,068 | $9,579 | $617 | $114,181 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$30,445 | -$53,623 | -$25,972 | $96,686 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37,142 | $90,765 | $116,737 | $20,051 |
| End Cash | $6,697 | $37,142 | $90,765 | $116,737 |
| Free Cash Flow | -$32,164 | -$36,704 | -$26,589 | -$17,495 |